查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1984927

2026年全球人工智慧（AI）远端肿瘤放射剂量调度器市场报告

Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，人工智慧驱动的远端肿瘤放射剂量计划软体市场发展迅速。预计该市场规模将从2025年的8.1亿美元成长到2026年的9.9亿美元，复合年增长率（CAGR）高达23.3%。成长要素包括：对远距癌症治疗计画的需求不断增长、远距肿瘤平台的广泛应用、对精确放射剂量计算的需求不断增长、人工智慧在肿瘤决策支援中的应用日益广泛、全球癌症发病率上升、医院数位化转型取得进展、云端医疗系统的广泛应用、放射治疗工作流程自动化需求的日益增长、对减少治疗的广泛治疗以及减少智能肿瘤排班工具的广泛治疗。

预计未来几年，人工智慧（AI）远距肿瘤放射剂量调度市场将大幅成长，到2030年将达到22.8亿美元，复合年增长率（CAGR）为23.0%。预测期内的成长要素包括：远端肿瘤网路的扩展、人工智慧驱动的治疗计画平台的普及、对自动化剂量运算系统需求的成长、基于云端的肿瘤调度模组的广泛应用、预测性肿瘤演算法的采用、远距放射线治疗治疗评估工具的开发、对精准癌症治疗的需求、人工智慧工具在肿瘤科室的整合、人工智慧供应商与癌症中心之间的合作，以及对癌症中心之间的远距放射线治疗流程的普及。预测期内的主要趋势包括：人工智慧驱动的放射治疗剂量预测的进步、基于云端的肿瘤治疗调度平台的进步、实时剂量优化引擎的进步、自动化治疗计划系统的创新、预测肿瘤算法的创新、虚拟放射肿瘤工作流程的创新、远程肿瘤学和医院信息系统的整合、人工智能剂量调度器和视频成像平台的集成肿瘤算法以及远程剂量审查以及远程远距放射线治疗的网络审查。

癌症发生率的上升预计将推动人工智慧（AI）远端肿瘤放射剂量调度系统市场的成长。癌症是一种以异常细胞不受控制地增生和扩散为特征的疾病，若不及时有效治疗，会损害周围组织和器官。不良饮食、吸烟、饮酒以及接触环境污染物等生活方式相关风​​险因素正在加剧癌症发病率的上升以及患有各种癌症的风险。人工智慧（AI）远端肿瘤放射剂量调度系统透过远端数据驱动分析，优化和个人化放射治疗方案，从而支持癌症管理。这些系统能够确保精准的剂量输送，减少治疗延误，并实现无论身处何地都能获得一致的治疗，进而改善患者的治疗效果。例如，根据英国政府机构NHS Digital的数据，截至2025年10月，英格兰地区2023年新增癌症病例354,820例，平均每天972例，比2022年增加8,605例。其中，摄护腺癌是最常见的新增病例，达58,137例，比上年度增加6%。因此，癌症发生率的上升正在推动人工智慧驱动的远端肿瘤放射剂量调度系统市场的成长。

在人工智慧远距肿瘤学和放射治疗市场主要企业正致力于开发先进的解决方案，例如人工智慧驱动的剂量预测，以预测个人化的放射剂量分布并简化治疗计划。人工智慧驱动的剂量预测平台是一种软体解决方案，它分析影像和解剖数据，产生临床可行的三维剂量分布，并支援及时调整以优化治疗。例如，2025年3月，总部位于芬兰的医疗科技公司MVision AI发表了「Dose+」。这款人工智慧驱动的剂量预测平台整合了专门针对前列腺癌和骨盆淋巴结病例的模型，能够根据每位患者的解剖结构优化剂量分布，并透过DICOM与标准治疗计划系统集成，从而实现高效的计划工作流程。此次发布标誌着人工智慧驱动的剂量预测在融入常规临床实践方面取得了重大技术进步，它将传统计划与以患者为中心的自动化流程相结合，并为临床医生提供了扩充性且高效的解决方案，以实现精准的个人化放射治疗。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球人工智慧（AI）远端肿瘤放射剂量调度器市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 自主系统、机器人、智慧运输
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 远端医疗计划的优化
    • 预测性辐射剂量计划
    • 自适应放射治疗的整合
    • 临床工作流程自动化
    • 人工智慧驱动的患者预后分析

第五章 终端用户产业市场分析

  • 医院
  • 癌症治疗中心
  • 研究机构
  • 肿瘤诊所
  • 远端医疗服务供应商

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球人工智慧（AI）远端肿瘤放射剂量调度市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球人工智慧（AI）远端肿瘤放射剂量调度器市场规模、对比及成长率分析
  • 全球人工智慧（AI）远端肿瘤放射剂量调度器市场表现：规模和成长，2020-2025年
  • 全球人工智慧（AI）远端肿瘤放射剂量调度市场预测：规模和成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按组件
  • 软体、硬体和服务
  • 透过技术
  • 机器学习演算法、自然语言处理、电脑视觉、预测分析
  • 部署模式
  • 本地部署（本地部署）、云端部署（SaaS）、混合部署
  • 透过使用
  • 自动勾勒轮廓和分割（危及器官或目标区）、治疗计划产生和最佳化、剂量预测和品质保证（QA）、工作流程和资源调度优化、自适应放射治疗计划。
  • 最终用户
  • 医院、癌症治疗中心、研究机构和其他最终用户
  • 按类型细分：软体
  • 分析和报告软体、建议引擎软体、自然语言处理软体、机器学习模型管理工具、电脑视觉软体、整合和API管理软体、行动和Web应用程式软体
  • 按类型细分：硬体
  • 人工智慧优化伺服器、边缘运算设备、感测器和物联网设备、智慧摄影机、GPU 和人工智慧加速器、储存系统、网路和连接硬体
  • 按类型细分：服务
  • 咨询服务、实施和整合服务、培训和支援服务、託管人工智慧服务、维护和升级服务、客製化人工智慧开发服务、资料管理和标註服务

第十章 区域与国别分析

  • 全球人工智慧（AI）远端肿瘤放射剂量调度市场：按地区划分，历史资料及预测，2020-2025年、2025-2030年、2035年
  • 全球人工智慧（AI）远端肿瘤放射剂量调度市场：按国家划分，历史资料及预测，2020-2025年、2025-2030年、2035年

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 人工智慧（AI）远端肿瘤放射剂量调度市场：竞争格局和市场份额，2024年
  • 人工智慧（AI）远端肿瘤放射剂量调度市场：公司估值矩阵
  • 人工智慧（AI）远端肿瘤放射剂量调度市场：公司概况
    • IBM Corporation
    • Siemens Healthineers AG
    • GE HealthCare Technologies Inc.
    • Koninklijke Philips NV
    • Varian Medical Systems Inc.

第37章 其他大型企业和创新企业

  • Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., Accuray Incorporated, Brainlab AG, RaySearch Laboratories AB, MIM Software Inc., Sun Nuclear Corp., DeepHealth, Radformation Inc., MVision AI Ltd., Mirada Medical Ltd., ViewRay Inc., Oncora Medical, Enlitic, Optellum Ltd.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：具有高市场潜力的国家、细分市场与策略

  • 2030年人工智慧（AI）远端肿瘤放射剂量调度市场：提供新机会的国家
  • 2030年人工智慧（AI）远端肿瘤放射剂量调度市场：提供新机会的细分市场
  • 2030年人工智慧（AI）远端肿瘤放射剂量调度市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: HS6MATOR02_G26Q1

An artificial intelligence (AI) tele-oncology radiation dose scheduler is a digital system that uses AI to assist clinicians in planning, adjusting, and optimizing radiation dose schedules remotely. It analyzes clinical, imaging, and treatment data to provide patient-specific dosing recommendations. This technology enhances accuracy, reduces planning time, and supports efficient remote oncology workflows.

The primary components of AI tele-oncology radiation dose schedulers consist of software, hardware, and services. Software includes AI-enabled scheduling and planning platforms that automate dose planning, coordinate workflows, and optimize resources for remote and centralized radiation oncology operations. These systems utilize technologies such as machine learning, natural language processing, computer vision, and predictive analytics, and are deployed through on-premises, cloud-based, and hybrid models. Applications include auto-contouring and segmentation, treatment plan generation and optimization, dose prediction and quality assurance, workflow and resource scheduling, and adaptive radiotherapy planning, used by hospitals, cancer treatment centers, research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have affected the ai tele-oncology radiation dose scheduler market by increasing the cost of importing ai-optimized servers, edge computing devices, and specialized radiotherapy hardware. this has slowed deployment in regions dependent on imported equipment, particularly in asia-pacific and latin america. segments such as hardware and ai software services are most impacted, while cloud-based deployment and remote consultation services may benefit from local alternatives. overall, tariffs have pushed manufacturers to explore localized production and diversified sourcing strategies to maintain market growth.

The artificial intelligence (AI) tele-oncology radiation dose scheduler market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) tele-oncology radiation dose scheduler market statistics, including artificial intelligence (AI) tele-oncology radiation dose scheduler industry global market size, regional shares, competitors with a artificial intelligence (AI) tele-oncology radiation dose scheduler market share, detailed artificial intelligence (AI) tele-oncology radiation dose scheduler market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) tele-oncology radiation dose scheduler industry. This artificial intelligence (AI) tele-oncology radiation dose scheduler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) tele-oncology radiation dose scheduler market size has grown expoentially in recent years. It will grow from $0.81 billion in 2025 to $0.99 billion in 2026 at a compound annual growth rate (CAGR) of 23.3%. The growth in the historic period can be attributed to increasing need for remote cancer treatment planning, rising adoption of tele-oncology platforms, growing demand for precise radiation dose calculation, increasing use of ai in oncology decision support, rising cancer incidence worldwide, growing digital transformation in hospitals, increasing deployment of cloud-based medical systems, rising need for workflow automation in radiotherapy, growing focus on reducing treatment errors, increasing adoption of smart oncology scheduling tools.

The artificial intelligence (AI) tele-oncology radiation dose scheduler market size is expected to see exponential growth in the next few years. It will grow to $2.28 billion in 2030 at a compound annual growth rate (CAGR) of 23.0%. The growth in the forecast period can be attributed to expansion of tele-oncology networks, adoption of ai-enabled treatment planning platforms, rising demand for automated dose calculation systems, uptake of cloud-based oncology scheduling modules, deployment of predictive oncology algorithms, development of remote radiotherapy review tools, demand for precision-based cancer care, integration of ai tools into oncology departments, partnerships between ai vendors and cancer centers, growing acceptance of tele-radiation workflows. Major trends in the forecast period include advancement in ai-driven radiotherapy dose prediction, advancement in cloud-based oncology scheduling platforms, advancement in real-time dose optimization engines, innovation in automated treatment planning systems, innovation in predictive oncology algorithms, innovation in virtual radiation oncology workflows, integration of tele-oncology with hospital info systems, integration of ai dose schedulers with imaging platforms, integration of remote dose-review tools for oncologists, integration of multi-center tele-radiation networks.

The rising prevalence of cancer is expected to propel the growth of the artificial intelligence (AI) tele-oncology radiation dose scheduler market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells that can damage surrounding tissues and organs if not treated effectively. The prevalence of cancer is increasing due to lifestyle-related risks such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, elevating the risk of developing various cancers. Artificial intelligence (AI) tele-oncology radiation dose schedulers support cancer management by optimizing and personalizing radiation treatment plans through remote, data-driven analysis. They improve patient outcomes by ensuring accurate dosing, reducing treatment delays, and enabling consistent care across locations. For instance, in October 2025, according to NHS Digital, a UK government organisation, there were 354,820 new cancer diagnoses recorded in England in 2023, averaging 972 diagnoses per day and representing an increase of 8,605 cases compared to 2022, with prostate cancer being the most commonly diagnosed at 58,137 new cases, reflecting a 6% increase in registrations compared to the previous year. Therefore, the rising prevalence of cancer is driving the growth of the artificial intelligence (AI) tele-oncology radiation dose scheduler market.

Key players operating in the AI tele-oncology and radiation therapy market are focusing on developing advanced solutions, such as AI-powered dose prediction, to predict personalized radiation dose distributions and improve treatment planning efficiency. AI-powered dose prediction platforms are software solutions used to analyze imaging and anatomical data, generate clinically achievable 3D dose distributions, and support timely adjustments to optimize therapy. For instance, in March 2025, MVision AI, a Finland-based health-tech company, launched Dose+. This AI-powered dose prediction platform incorporates specialized models for prostate and pelvic lymph node cases, tailors dose distributions to each patient's anatomy, and supports integration with standard treatment planning systems via DICOM to facilitate efficient planning workflows. This launch represents a significant technological advancement by integrating AI-driven dose prediction into routine clinical practice, bridging traditional planning with automated, patient-specific optimization, and providing clinicians with a scalable, efficient solution for precise, personalized radiation therapy.

In October 2024, Baylor College of Medicine, a US-based academic health science center, partnered with mVIZION.ai Inc. to advance AI innovations in radiation therapy planning and delivery. Through this collaboration, Baylor College of Medicine and mVIZION.ai aim to develop and refine AI-powered radiation dose scheduling and optimization tools that support personalized treatment regimens, reduce variability in therapy delivery, and improve clinical outcomes in oncology care. mVIZION.ai Inc. is a US-based artificial intelligence healthcare company.

Major companies operating in the artificial intelligence (AI) tele-oncology radiation dose scheduler market are IBM Corporation, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Varian Medical Systems Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., Accuray Incorporated, Brainlab AG, RaySearch Laboratories AB, MIM Software Inc., Sun Nuclear Corp., DeepHealth, Radformation Inc., MVision AI Ltd., Mirada Medical Ltd., ViewRay Inc., Oncora Medical, Enlitic, Optellum Ltd.

North America was the largest region in the AI tele-oncology radiation dose scheduler market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) tele-oncology radiation dose scheduler market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) tele-oncology radiation dose scheduler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) tele-oncology radiation dose scheduler market consists of revenues earned by entities by providing services such as remote radiation dose planning services, AI-driven treatment scheduling, tele-consultation support for oncology dosing, cloud-based radiation planning assistance and real-time dose adjustment analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) tele-oncology radiation dose scheduler market consists of sales of AI radiation planning software, tele-oncology workflow platforms, cloud-based dose scheduling tools, automated treatment optimization algorithms, and radiation dose calculation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai) tele-oncology radiation dose scheduler market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) tele-oncology radiation dose scheduler ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) tele-oncology radiation dose scheduler market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Technology: Machine Learning Algorithms; Natural Language Processing; Computer Vision; Predictive Analytics
  • 3) By Deployment Mode: On-Premise (Local Installation); Cloud-Based (SaaS); Hybrid Deployment
  • 4) By Application: Auto-Contouring And Segmentation (OAR Or Target); Treatment Plan Generation And Optimization; Dose Prediction And Quality Assurance (QA); Workflow And Resource Scheduling Optimization; Adaptive Radiotherapy Planning
  • 5) By End-User: Hospitals; Cancer Treatment Centers; Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Software: Analytics And Reporting Software; Recommendation Engine Software; Natural Language Processing Software; Machine Learning Model Management Tools; Computer Vision Software; Integration And API Management Software; Mobile And Web Application Software
  • 2) By Hardware: AI-Optimized Servers; Edge Computing Devices; Sensors And IoT Devices; Smart Cameras; GPUs And AI Accelerators; Storage Systems; Networking And Connectivity Hardware
  • 3) By Services: Consulting Services; Implementation And Integration Services; Training And Support Services; Managed AI Services; Maintenance And Upgradation Services; Custom AI Development Services; Data Management And Annotation Services
  • Companies Mentioned: IBM Corporation; Siemens Healthineers AG; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; Varian Medical Systems Inc.; Elekta AB; Shanghai United Imaging Healthcare Co. Ltd.; Accuray Incorporated; Brainlab AG; RaySearch Laboratories AB; MIM Software Inc.; Sun Nuclear Corp.; DeepHealth; Radformation Inc.; MVision AI Ltd.; Mirada Medical Ltd.; ViewRay Inc.; Oncora Medical; Enlitic; Optellum Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Remote Treatment Planning Optimization
    • 4.2.2 Predictive Radiation Dose Scheduling
    • 4.2.3 Adaptive Radiotherapy Integration
    • 4.2.4 Clinical Workflow Automation
    • 4.2.5 Ai-Based Patient Outcome Analytics

5. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cancer Treatment Centers
  • 5.3 Research Institutes
  • 5.4 Oncology Clinics
  • 5.5 Telemedicine Service Providers

6. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Segmentation

  • 9.1. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Hardware, Services
  • 9.2. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Machine Learning Algorithms, Natural Language Processing, Computer Vision, Predictive Analytics
  • 9.3. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • On-Premise (Local Installation), Cloud-Based (SaaS), Hybrid Deployment
  • 9.4. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Auto-Contouring And Segmentation (OAR Or Target), Treatment Plan Generation And Optimization, Dose Prediction And Quality Assurance (QA), Workflow And Resource Scheduling Optimization, Adaptive Radiotherapy Planning
  • 9.5. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Cancer Treatment Centers, Research Institutes, Other End-Users
  • 9.6. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Analytics And Reporting Software, Recommendation Engine Software, Natural Language Processing Software, Machine Learning Model Management Tools, Computer Vision Software, Integration And API Management Software, Mobile And Web Application Software
  • 9.7. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • AI-Optimized Servers, Edge Computing Devices, Sensors And IoT Devices, Smart Cameras, GPUs And AI Accelerators, Storage Systems, Networking And Connectivity Hardware
  • 9.8. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting Services, Implementation And Integration Services, Training And Support Services, Managed AI Services, Maintenance And Upgradation Services, Custom AI Development Services, Data Management And Annotation Services

10. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Regional And Country Analysis

  • 10.1. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 11.1. Asia-Pacific Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 12.1. China Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 13.1. India Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 14.1. Japan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 15.1. Australia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 16.1. Indonesia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 17.1. South Korea Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 18.1. Taiwan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 19.1. South East Asia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 20.1. Western Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 21.1. UK Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 22.1. Germany Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 23.1. France Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 24.1. Italy Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 25.1. Spain Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 26.1. Eastern Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 27.1. Russia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 28.1. North America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 29.1. USA Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 30.1. Canada Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 31.1. South America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 32.1. Brazil Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 33.1. Middle East Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

  • 34.1. Africa Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Competitive Landscape And Company Profiles

  • 36.1. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Company Profiles
    • 36.3.1. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Other Major And Innovative Companies

  • Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., Accuray Incorporated, Brainlab AG, RaySearch Laboratories AB, MIM Software Inc., Sun Nuclear Corp., DeepHealth, Radformation Inc., MVision AI Ltd., Mirada Medical Ltd., ViewRay Inc., Oncora Medical, Enlitic, Optellum Ltd.

38. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

40. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market High Potential Countries, Segments and Strategies

  • 40.1 Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer